Skip to main content

Table 1 Patient population and control subjects used for the sPLA2 measurements.

From: Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis

Group

n (F/M)

Age yrs ± sd

MS Onset yrs ± sd

MS Duration yrs ± sd

βIF

GA

None

Active

12 (8/4)

38.2 ± 9.5

29.5 ± 8.9

7.3 ± 4.5

9

1

2

Stable

32 (25/7)

43.6 ± 8.1

33.4 ± 8.6

10.6 ± 9.3

15

3

14

Control

14 (9/5)

37.5 ± 9.0

-

-

-

-

-

  1. The means of subject age, age of MS onset, duration of the disease, and ongoing therapies are listed. F/M = female/male; βIF = beta-interferon; GA = glatiramer acetate; sd = standard deviation.
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094